Catherine O. Buck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Catherine O. Buck has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Veronika Shabanova
Department of Pediatrics, Yale School of Medicine, New Haven, USA
8 shared publicationsSarah N. Taylor
Department of Pediatrics Yale School of Medicine Connecticut USA
4 shared publications- Sarah N. Taylor
Department of Pediatrics, Yale University School of Medicine, New Haven, USA
4 shared publications Aimin Chen
Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publicationsBruce P. Lanphear
Faculty of Health Sciences Simon Fraser University Burnaby British Columbia Canada
3 shared publicationsJoseph M. Braun
Department of Epidemiology School of Public Health Brown University Providence Rhode Island USA
3 shared publications
Latest Publications
- 29 June 2026
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (9) , 1-8
Metabolic health conditions in pregnancy, human milk hormone concentrations, and infant adiposity
Objective To explore differences in human milk hormones with metabolic conditions (obesity and/or diabetes) during pregnancy and the relationship with infant adiposity. Study design In a prospective cohort of term and preterm infants, hormones were measured in early human milk, and growth was assessed at discharge. Differences in hormones by metabolic conditions and the relationship with growth were modeled using quantile and linear regression. Result Among 38 infants (mean gestational age 35.2 weeks), 50% were in the metabolic-group. Milk leptin was higher in the metabolic-group, with median difference 427 pg/mL (95% CI: 3.2, 850.9). After adjustment for exposure to maternal milk, each 10-fold change in leptin related to 2.1 cm (95% CI: 0.3, 4.2) increase in abdominal circumference and each 10-fold change in insulin related to 1.1 cm (95% CI: 0.03, 2.1) increase in mid-arm circumference, while other effects were attenuated. Conclusion In this explorative study, leptin was higher in human milk from women with metabolic conditions, and human milk hormones predicted growth at discharge.
- 29 June 2026
- Published by Springer Nature in Journal of Perinatology
- Vol. 46 (9) , 1-8
Metabolic health conditions in pregnancy, human milk hormone concentrations, and infant adiposity
Objective To explore differences in human milk hormones with metabolic conditions (obesity and/or diabetes) during pregnancy and the relationship with infant adiposity. Study design In a prospective cohort of term and preterm infants, hormones were measured in early human milk, and growth was assessed at discharge. Differences in hormones by metabolic conditions and the relationship with growth were modeled using quantile and linear regression. Result Among 38 infants (mean gestational age 35.2 weeks), 50% were in the metabolic-group. Milk leptin was higher in the metabolic-group, with median difference 427 pg/mL (95% CI: 3.2, 850.9). After adjustment for exposure to maternal milk, each 10-fold change in leptin related to 2.1 cm (95% CI: 0.3, 4.2) increase in abdominal circumference and each 10-fold change in insulin related to 1.1 cm (95% CI: 0.03, 2.1) increase in mid-arm circumference, while other effects were attenuated. Conclusion In this explorative study, leptin was higher in human milk from women with metabolic conditions, and human milk hormones predicted growth at discharge.
- Open Access
- 24 June 2026
- Published by Academia.edu in Academia Nutrition and Dietetics
- Vol. 3 (2)
Fluid intake in term and preterm infants exposed to maternal diabetes
Introduction: Diabetes (DM) in pregnancy is associated with obesity and cardiometabolic abnormalities in childhood. Our prior work has shown that preterm infants exposed to DM in pregnancy have differences in early growth trajectory compared with preterm infants not exposed to DM. The influence of early nutrition on growth patterns in preterm infants exposed to DM in pregnancy is not known. The objective of this study was to examine the influence of DM in pregnancy on early total fluid intake (TFI) and weight change during newborn hospitalization. Materials and methods: In a prospective cohort of preterm (30–36 weeks) and term infants, nutrition information was obtained from the medical record and adjusted linear mixed effects models used to determine differences in average TFI between DM exposure groups. Results: Among 149 infants, the DM group (n = 50) had less exclusive breastfeeding on day 1. DM group infants had higher TFI (ml/day) in the first postnatal week, which was explained by infant weight. Among late preterm infants, the DM group had accelerated weight between postnatal day 7 and 14 compared with the non-DM group, which correlated with lower TFI for weight (ml/kg/day) on days 3 and 14. Conclusions: The observed differences in TFI in this cohort may be related to feeding maturity in this at-risk population.
- 24 June 2026
- Published by Academia.edu in Academia Nutrition and Dietetics
- Vol. 3 (2)
Open AccessFluid intake in term and preterm infants exposed to maternal diabetes
Introduction: Diabetes (DM) in pregnancy is associated with obesity and cardiometabolic abnormalities in childhood. Our prior work has shown that preterm infants exposed to DM in pregnancy have differences in early growth trajectory compared with preterm infants not exposed to DM. The influence of early nutrition on growth patterns in preterm infants exposed to DM in pregnancy is not known. The objective of this study was to examine the influence of DM in pregnancy on early total fluid intake (TFI) and weight change during newborn hospitalization. Materials and methods: In a prospective cohort of preterm (30–36 weeks) and term infants, nutrition information was obtained from the medical record and adjusted linear mixed effects models used to determine differences in average TFI between DM exposure groups. Results: Among 149 infants, the DM group (n = 50) had less exclusive breastfeeding on day 1. DM group infants had higher TFI (ml/day) in the first postnatal week, which was explained by infant weight. Among late preterm infants, the DM group had accelerated weight between postnatal day 7 and 14 compared with the non-DM group, which correlated with lower TFI for weight (ml/kg/day) on days 3 and 14. Conclusions: The observed differences in TFI in this cohort may be related to feeding maturity in this at-risk population.
- 20 June 2026
- Published by Elsevier in Seminars in Perinatology
- Vol. 50 (5) , 152272
Nutrition beyond the neonatal intensive care unit: Best practices and optimal outcome measures
- 20 June 2026
- Published by Elsevier in Seminars in Perinatology
- Vol. 50 (5) , 152272
Nutrition beyond the neonatal intensive care unit: Best practices and optimal outcome measures
- Open Access
- 12 March 2026
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (6) , e70431
Urine Metabolism Biomarkers Predict Preterm Infant Adiposity at Hospital Discharge
In infants born to women with diabetes (DM), this study explores associations of urinary metabolite patterns with adiposity development in the newborn period. In term and preterm (30‐36 weeks gestational age) infants, body composition assessments were completed at hospital discharge. In urine samples from the first week, a targeted metabolomics assay was used. Quantile regression was used to evaluate associations of metabolite groups with DM in pregnancy and infant adiposity. Among 91 infants, 25 (27%) were exposed to DM, 68 (75%) were preterm. In the factor analysis, there was an association between factor 4 score (fatty acid and amino acid metabolites) and triceps skin fold thickness (β = 1.67 [95%CI: 0.62, 2.72]) and mid arm circumference (β = 1.59 [95%CI: 0.70, 2.49]) in preterm‐DM group. Urinary C2, C3, and ornithine were decreased in DM‐group (fold change 2.7, p<0.0001). In this cohort, infant urinary amino acid and acylcarnitine concentrations varied by DM during pregnancy and gestational age and were differentially related to postnatal adiposity in preterm DM‐group. Unique signatures of urinary metabolites may reflect early metabolism changes in the developing infant.
- 12 March 2026
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (6) , e70431
Open AccessUrine Metabolism Biomarkers Predict Preterm Infant Adiposity at Hospital Discharge
In infants born to women with diabetes (DM), this study explores associations of urinary metabolite patterns with adiposity development in the newborn period. In term and preterm (30‐36 weeks gestational age) infants, body composition assessments were completed at hospital discharge. In urine samples from the first week, a targeted metabolomics assay was used. Quantile regression was used to evaluate associations of metabolite groups with DM in pregnancy and infant adiposity. Among 91 infants, 25 (27%) were exposed to DM, 68 (75%) were preterm. In the factor analysis, there was an association between factor 4 score (fatty acid and amino acid metabolites) and triceps skin fold thickness (β = 1.67 [95%CI: 0.62, 2.72]) and mid arm circumference (β = 1.59 [95%CI: 0.70, 2.49]) in preterm‐DM group. Urinary C2, C3, and ornithine were decreased in DM‐group (fold change 2.7, p<0.0001). In this cohort, infant urinary amino acid and acylcarnitine concentrations varied by DM during pregnancy and gestational age and were differentially related to postnatal adiposity in preterm DM‐group. Unique signatures of urinary metabolites may reflect early metabolism changes in the developing infant.
- 9 April 2025
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 30 (2) , 101637
Post-discharge nutrition to optimize preterm infant short- and long-term outcomes
- 9 April 2025
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 30 (2) , 101637
Post-discharge nutrition to optimize preterm infant short- and long-term outcomes
- 3 April 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (8) , 1177-1179
What is the best nutritional strategy for moderate to late preterm infants?
- 3 April 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (8) , 1177-1179
What is the best nutritional strategy for moderate to late preterm infants?
- 22 March 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (5) , 622-627
Alterations in infant adipokine concentrations in the first postnatal week with exposure to diabetes in pregnancy
- 22 March 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (5) , 622-627
Alterations in infant adipokine concentrations in the first postnatal week with exposure to diabetes in pregnancy
- 17 January 2025
- Published by Springer Nature in Pediatric Research
- Vol. 98 (3) , 1023-1032
Alterations in newborn metabolite patterns with preterm birth and diabetes in pregnancy
Background This study examines the influence of prematurity and diabetes (DM) in pregnancy on metabolite patterns at birth, and associations with adiposity development in a prospective cohort. Methods Term and preterm (30-36 weeks gestational age [GA]) infants were enrolled and body composition assessments completed through discharge. Targeted metabolomics was used to assess metabolites in cord or infant blood in the first 2 days. Results Among 91 infants, 62 were preterm and 27 were exposed to DM. In factor analysis, variation in acylcarnitines’ and non-essential amino acids differed by GA and DM exposure and were associated with adiposity at term age. DM-group had 1.95-fold increase in t4-OH-pro (p = 0.003) and 2.14-fold increase in taurine (p = 0.004) compared with non-DM group. Preterm infants had 1.77-fold increase in glycerophospholipid PC aa C32:2 versus term group (p < 0.001). Pathway analysis revealed differences across DM and GA groups in pathways associated with citrulline metabolism, amino acid transport/ synthesis, and fatty acid quantity/transport. Conclusion In this cohort of infants, there are unique metabolite signatures associated with DM exposure, prematurity, and adiposity development after birth. These markers may reflect early metabolism changes in the developing infant which relate to known risks of adverse growth and cardiometabolic outcomes in this group. Impact In this study of term and preterm infants, diabetes in pregnancy was associated with unique metabolic signatures at birth, including increased expression of metabolites related to protein synthesis and lipid metabolism. Metabolites related to lipid and protein metabolism were associated with adiposity development at term age, including estimated body fat percent, skin fold thickness measures, and arm circumference measures. Unique signatures of metabolites associated with prematurity and exposure to diabetes in pregnancy may reflect early metabolism changes in the developing infant which relate to known risks of adverse growth and cardiometabolic outcomes in this group.
- 17 January 2025
- Published by Springer Nature in Pediatric Research
- Vol. 98 (3) , 1023-1032
Alterations in newborn metabolite patterns with preterm birth and diabetes in pregnancy
Background This study examines the influence of prematurity and diabetes (DM) in pregnancy on metabolite patterns at birth, and associations with adiposity development in a prospective cohort. Methods Term and preterm (30-36 weeks gestational age [GA]) infants were enrolled and body composition assessments completed through discharge. Targeted metabolomics was used to assess metabolites in cord or infant blood in the first 2 days. Results Among 91 infants, 62 were preterm and 27 were exposed to DM. In factor analysis, variation in acylcarnitines’ and non-essential amino acids differed by GA and DM exposure and were associated with adiposity at term age. DM-group had 1.95-fold increase in t4-OH-pro (p = 0.003) and 2.14-fold increase in taurine (p = 0.004) compared with non-DM group. Preterm infants had 1.77-fold increase in glycerophospholipid PC aa C32:2 versus term group (p < 0.001). Pathway analysis revealed differences across DM and GA groups in pathways associated with citrulline metabolism, amino acid transport/ synthesis, and fatty acid quantity/transport. Conclusion In this cohort of infants, there are unique metabolite signatures associated with DM exposure, prematurity, and adiposity development after birth. These markers may reflect early metabolism changes in the developing infant which relate to known risks of adverse growth and cardiometabolic outcomes in this group. Impact In this study of term and preterm infants, diabetes in pregnancy was associated with unique metabolic signatures at birth, including increased expression of metabolites related to protein synthesis and lipid metabolism. Metabolites related to lipid and protein metabolism were associated with adiposity development at term age, including estimated body fat percent, skin fold thickness measures, and arm circumference measures. Unique signatures of metabolites associated with prematurity and exposure to diabetes in pregnancy may reflect early metabolism changes in the developing infant which relate to known risks of adverse growth and cardiometabolic outcomes in this group.
- 2 January 2025
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 37 (2) , 191-197
Utilizing preterm infant body composition assessments to guide neonatal nutrition
Purpose of review: The use of body composition to assess the quality of infant growth may add valuable information to pediatric clinical care. Preterm infants have differences in their fat and muscle mass development compared with infants born at term, which may be related to their early nutritional exposures. This review focuses on recent studies examining early nutrition in preterm infants and related body composition outcomes in the newborn period and beyond. Recent findings: Overall, the evidence shows that early nutrient delivery in parenteral nutrition and through formula supplementation or human milk fortification is associated with increased fat-free mass or lean mass in early life. However, future research is needed to fully understand the link between these body composition changes and longitudinal outcomes in preterm infants. Summary: Inclusion of body composition assessments in preterm infant nutrition research is critical to understand the factors associated with differences in adiposity and lean mass development in preterm infants. Medical fragility in preterm infants limits the routine use of body composition assessment tools which are currently validated, and additional studies are needed to thoroughly assess other methods which may be more feasible to integrate into bedside routine.
- 2 January 2025
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 37 (2) , 191-197
Utilizing preterm infant body composition assessments to guide neonatal nutrition
Purpose of review: The use of body composition to assess the quality of infant growth may add valuable information to pediatric clinical care. Preterm infants have differences in their fat and muscle mass development compared with infants born at term, which may be related to their early nutritional exposures. This review focuses on recent studies examining early nutrition in preterm infants and related body composition outcomes in the newborn period and beyond. Recent findings: Overall, the evidence shows that early nutrient delivery in parenteral nutrition and through formula supplementation or human milk fortification is associated with increased fat-free mass or lean mass in early life. However, future research is needed to fully understand the link between these body composition changes and longitudinal outcomes in preterm infants. Summary: Inclusion of body composition assessments in preterm infant nutrition research is critical to understand the factors associated with differences in adiposity and lean mass development in preterm infants. Medical fragility in preterm infants limits the routine use of body composition assessment tools which are currently validated, and additional studies are needed to thoroughly assess other methods which may be more feasible to integrate into bedside routine.
- 17 September 2024
- Published by Springer Nature in Pediatric Research
- Vol. 96 (7) , 1529
ECI biocommentary: Catherine Buck
- 17 September 2024
- Published by Springer Nature in Pediatric Research
- Vol. 96 (7) , 1529
ECI biocommentary: Catherine Buck